Matches in Wikidata for { <http://www.wikidata.org/entity/Q90763675> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q90763675 description "article scientifique publié en 2018" @default.
- Q90763675 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q90763675 description "im Juli 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90763675 description "scientific article published on 20 July 2018" @default.
- Q90763675 description "wetenschappelijk artikel" @default.
- Q90763675 description "наукова стаття, опублікована в липні 2018" @default.
- Q90763675 name "CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance" @default.
- Q90763675 name "CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance" @default.
- Q90763675 type Item @default.
- Q90763675 label "CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance" @default.
- Q90763675 label "CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance" @default.
- Q90763675 prefLabel "CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance" @default.
- Q90763675 prefLabel "CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance" @default.
- Q90763675 P1433 Q90763675-16B23BCC-261A-4741-8378-E50D30E76688 @default.
- Q90763675 P1476 Q90763675-6D8265D3-E3F4-41A1-9C89-DA5E69FE645E @default.
- Q90763675 P2093 Q90763675-0D285FD6-E33C-47C3-B59C-17DB6015E9B8 @default.
- Q90763675 P2093 Q90763675-1361AB79-A489-4276-8AE6-F238EA2AAC17 @default.
- Q90763675 P2093 Q90763675-42BE65D6-C8DD-49AE-A2ED-756AA49D7CF6 @default.
- Q90763675 P2093 Q90763675-608CE994-937D-493C-8F17-15E41F6110BB @default.
- Q90763675 P2093 Q90763675-678CA8CC-DA86-4350-A819-05FD7FB450F9 @default.
- Q90763675 P2093 Q90763675-7750B16A-926A-405D-B766-7AF21D8347F6 @default.
- Q90763675 P2093 Q90763675-86023867-7DE5-4164-BD3B-E06DBC38E9BF @default.
- Q90763675 P2093 Q90763675-91B19381-3036-481D-BC47-17F9D3C37C5E @default.
- Q90763675 P2093 Q90763675-A6DDEE9C-7C7E-49C4-938B-76664DD00797 @default.
- Q90763675 P2093 Q90763675-ABE24C0B-12A4-4BD8-B9BD-E7C810B672B0 @default.
- Q90763675 P2093 Q90763675-B40B457E-E532-4B76-8055-E051D5AC31CB @default.
- Q90763675 P2093 Q90763675-EFFDA44D-C27B-4476-9CCD-4F543A2721E4 @default.
- Q90763675 P2093 Q90763675-F0FC3ABB-B194-45B6-BB5A-343096D8A63A @default.
- Q90763675 P275 Q90763675-4ca7d7cf-5151-4e40-8671-31690964ec9e @default.
- Q90763675 P2860 Q90763675-37E3BB60-D68E-4BD7-8AF6-B5972FB469A8 @default.
- Q90763675 P304 Q90763675-E08922EB-60C0-4B31-9C0C-8B4E846EE60D @default.
- Q90763675 P31 Q90763675-C6882550-86BC-4489-B3D3-19F51A911405 @default.
- Q90763675 P356 Q90763675-4E818CD1-B4D5-4DA5-AD42-A51F3736E8CF @default.
- Q90763675 P4510 Q90763675-7135F674-6D10-4588-8087-92E21F778506 @default.
- Q90763675 P478 Q90763675-79BC2582-7FA7-46B7-8765-3F5F500DB60F @default.
- Q90763675 P577 Q90763675-5B8FA82C-B254-482A-94A2-A8532B0A1361 @default.
- Q90763675 P6216 Q90763675-5ca383b9-7766-4ce0-8753-f1d0919f581f @default.
- Q90763675 P698 Q90763675-2BF5B692-3721-4D9E-B13E-2CD6607AF223 @default.
- Q90763675 P921 Q90763675-481F0EF9-4616-46F0-B0C7-E5E5EE93E3AB @default.
- Q90763675 P932 Q90763675-EDC06D95-909E-40A0-995A-016ACFC658EC @default.
- Q90763675 P356 FIMMU.2018.01676 @default.
- Q90763675 P698 30079070 @default.
- Q90763675 P1433 Q27723748 @default.
- Q90763675 P1476 "CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance" @default.
- Q90763675 P2093 "Anja Seckinger" @default.
- Q90763675 P2093 "Anna Jauch" @default.
- Q90763675 P2093 "Anthony D Ho" @default.
- Q90763675 P2093 "Christoph Kimmich" @default.
- Q90763675 P2093 "Dirk Hose" @default.
- Q90763675 P2093 "Jens Hillengass" @default.
- Q90763675 P2093 "Marc-Steffen Raab" @default.
- Q90763675 P2093 "Martina Emde" @default.
- Q90763675 P2093 "Michael Hundemer" @default.
- Q90763675 P2093 "Stefan Schönland" @default.
- Q90763675 P2093 "Susanne Beck" @default.
- Q90763675 P2093 "Tobias Dittrich" @default.
- Q90763675 P2093 "Ute Hegenbart" @default.
- Q90763675 P275 Q20007257 @default.
- Q90763675 P2860 Q21194861 @default.
- Q90763675 P304 "1676" @default.
- Q90763675 P31 Q13442814 @default.
- Q90763675 P356 "10.3389/FIMMU.2018.01676" @default.
- Q90763675 P4510 Q113334690 @default.
- Q90763675 P478 "9" @default.
- Q90763675 P577 "2018-07-20T00:00:00Z" @default.
- Q90763675 P6216 Q50423863 @default.
- Q90763675 P698 "30079070" @default.
- Q90763675 P921 Q1427096 @default.
- Q90763675 P932 "6062598" @default.